Navarrete, F., García-Gutiérrez, M. S., Aracil-Fernández, A., Lanciego, J. L., & Manzanares, J. (2018). Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Patients with Parkinson’s Disease. Neurotherapeutics.
Chicago Style CitationNavarrete, Francisco, M. Salud García-Gutiérrez, Auxiliadora Aracil-Fernández, José L. Lanciego, i Jorge Manzanares. "Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Patients With Parkinson’s Disease." Neurotherapeutics 2018.
Cita MLANavarrete, Francisco, et al. "Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Patients With Parkinson’s Disease." Neurotherapeutics 2018.